India · Delayed Price · Currency is INR Zydus Lifesciences Statistics
Total Valuation
BOM:532321 has a market cap or net worth of INR 1.12 trillion. The enterprise value is 1.22 trillion.
| Market Cap | 1.12T |
| Enterprise Value | 1.22T |
Important Dates
The last earnings date was Tuesday, August 11, 2026.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | Jul 24, 2026 |
Share Statistics
| Current Share Class | 997.50M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.02% |
| Shares Change (QoQ) | -0.08% |
| Owned by Insiders (%) | 75.68% |
| Owned by Institutions (%) | 15.96% |
| Float | 240.78M |
Valuation Ratios
The trailing PE ratio is 24.76 and the forward PE ratio is 25.98.
| PE Ratio | 24.76 |
| Forward PE | 25.98 |
| PS Ratio | 3.91 |
| PB Ratio | 3.78 |
| P/TBV Ratio | 11.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 52.78 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 26.97 |
| EV / Sales | 4.26 |
| EV / EBITDA | 17.55 |
| EV / EBIT | 22.34 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.42 |
| Debt / EBITDA | 1.83 |
| Debt / FCF | -9.80 |
| Interest Coverage | 12.26 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 10.84% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 9.54M |
| Profits Per Employee | 1.51M |
| Employee Count | 29,980 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:532321 has paid 15.15 billion in taxes.
| Income Tax | 15.15B |
| Effective Tax Rate | 24.80% |
Stock Price Statistics
The stock price has increased by +13.93% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +13.93% |
| 50-Day Moving Average | 1,122.31 |
| 200-Day Moving Average | 981.03 |
| Relative Strength Index (RSI) | 48.21 |
| Average Volume (20 Days) | 107,495 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532321 had revenue of INR 285.92 billion and earned 45.13 billion in profits. Earnings per share was 44.86.
| Revenue | 285.92B |
| Gross Profit | 206.18B |
| Operating Income | 53.49B |
| Pretax Income | 61.08B |
| Net Income | 45.13B |
| EBITDA | 68.07B |
| EBIT | 53.49B |
| Earnings Per Share (EPS) | 44.86 |
Balance Sheet
The company has 49.71 billion in cash and 125.15 billion in debt, with a net cash position of -75.44 billion.
| Cash & Cash Equivalents | 49.71B |
| Total Debt | 125.15B |
| Net Cash | -75.44B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 295.82B |
| Book Value Per Share | 269.43 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 21.17 billion and capital expenditures -33.94 billion, giving a free cash flow of -12.77 billion.
| Operating Cash Flow | 21.17B |
| Capital Expenditures | -33.94B |
| Depreciation & Amortization | 14.57B |
| Net Borrowing | 72.67B |
| Free Cash Flow | -12.77B |
| FCF Per Share | n/a |
Margins
Gross margin is 72.11%, with operating and profit margins of 18.71% and 15.78%.
| Gross Margin | 72.11% |
| Operating Margin | 18.71% |
| Pretax Margin | 21.36% |
| Profit Margin | 15.78% |
| EBITDA Margin | 23.81% |
| EBIT Margin | 18.71% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.09%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.09% |
| Dividend Growth (YoY) | -90.91% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.02% |
| Shareholder Yield | 0.11% |
| Earnings Yield | 4.04% |
| FCF Yield | -1.14% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BOM:532321 is 1,195.78, which is 6.77% higher than the current price. The consensus rating is "Hold".
| Price Target | 1,195.78 |
| Price Target Difference | 6.77% |
| Analyst Consensus | Hold |
| Analyst Count | 30 |
| Revenue Growth Forecast (3Y) | 11.47% |
| EPS Growth Forecast (3Y) | -0.20% |
Stock Splits
The last stock split was on October 6, 2015. It was a forward split with a ratio of 5.
| Last Split Date | Oct 6, 2015 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |